BOCA RATON, FL, - (http://www.financialnewsmedia.com News Alert) - Earth Science Tech, Inc. (OTCQB: ETST) ("ETST" or "the Company"), a unique biotechnology company focused on nutraceuticals, bioceuticals and dietary supplements, announced today that its CEO, Harvey Katz PhD, as well as the company, was featured in a live video and article done by the Cannabis Financial Network. This new coverage and live CEO interview featured by Cannabis Financial Network outlines the recent success ETST has made in rapidly growing and expanding its business as an emerging company on many fronts. Some of the featured highlights from this live CEO video and article on ETST include:
CBD-enriched hemp oil, which is completely legal in 50 states and over
40 countries worldwide (as per U.S. Hemp Foods specifications).
- ETST already began selling; shipping its High Grade CBD Rich Hemp oil
and an initial order to an outlet in Fort Lauderdale and its management
is working hard to drum up additional supply lines.
- ETST is moving towards widespread commercialization while setting
themselves up to be a high-volume throughput channel for high-grade CBD.
- ETST has already begun making their CBD products available online in
half-ounce, ounce and two ounce bottles, and has made sizeable
investments into their high-volume inventory model, with hundreds of
thousands of dollars already outlaid and ambitions to fill persistent
supply constraints in the CBD.
- ETST funded assistant dean of the University of Central Oklahoma's
College of Mathematics and Science, Wei R. Chen, Ph.D., with a $10k
grant to study the anti-tumor effects of its ETST Hemp oil enriched with
CBD on cancer cells, pushing the boundaries of the established anti-
tumor properties of CBD.
- ETST is developing a variety of nutraceuticals, bioceuticals and dietary
supplements for health, wellness, sports and alternative medicine, as
well as natural alternatives to prescription medications, both CBD and
- ETST has developed a unique menopause and perimenopause formula for
aging women known as ProgesteBeauty(TM), and the company is currently in
the process of opening the first retail location for their wholly-owned
Nutrition Empire, Inc. subsidiary in an upscale area of Coral Gables,
Florida. The retail footprint will help support product roll outs and
the company will also be working to dovetail their overall commercial
presence with key strategic partners and third party resellers who
already control chunks of the nutritional and supplement markets.
- ETST has secured a lease for their initial retail location, which is
situated right on the edge of the University of Miami campus, on the
first floor of a luxury apartment complex, that stipulates no other
nutrition or supplement store will be located within a three-mile
radius. This will also be the first retail store in all of Dade County
where consumers can walk right in and buy CBD oil over the counter, as
well as get their hands on ProgesteBeauty, or the company's soon-to-be-
released, oxygen-based colon cleanser with probiotics (L. rhamnosus and
L. acidophilus), OxyBiotic(TM).
- ETST goal is to have around 600 best-in-class health and wellness
products in-store, as well as a terminal for customers to order products
for next-day delivery, again emphasizing ready supply as a key brand
ETST is happy to see that the Cannabis Financial Network has taken notice that ETST is an emerging company delivering cutting edge Nutraceuticals, Bioceuticals and Dietary Supplements designed for excellence in the areas of Health, Wellness, Sports and Alternative Medicine. This also includes that fact that ETST looks to help improve the quality of life for Consumers Worldwide through the use of such products. ETST is also dedicated to providing Natural Alternatives to prescription medications through Nutritional Supplements and Dietary Supplements that help improve common disorders and illnesses. To read the coverage and article featured by the Cannabis Financial Network on ETST see below.
Earth Science Tech Brings High Grade CBD To 50 States Via Volume Inventory Model
Cannabis Financial Network / Whitefish, MT / By now nearly everyone has heard of the case of Charlotte Figi, a seven-year-old girl with Dravet Syndrome (a form of severe and intractable epilepsy), who was having as many as 50 seizures a day. In desperation, Charlotte's parents tried everything pharmaceutical science could throw at the problem, even debilitating drugs like barbiturates and benzodiazepines, in an ultimately futile attempt to curb the devastation. The father finally took the leap to try a low-THC (Tetrahydrocannabinol, the psychoactive component), CBD-rich (Cannabidiol) strain of medical marijuana known as Charlotte's Web and since dosing, his daughter has truly thrived, with only two to three seizures per month and a much-improved overall condition. A groundbreaking clinical trial is coming up to study Charlotte's Web in Dravet Syndrome at the University of Colorado and this study's results could provide a real boost to the CBD, as well as broader, medical marijuana markets.
The CBD market in particular has been growing by leaps and bounds in recent years, with heavy-hitters like GW Pharmaceuticals (GWPH) already seeing good traction on their Multiple Sclerosis treatment, Sativex(r), which clearly benefits a great deal from CBD's increasingly apparent pain-relieving, anti-inflammatory, and immunodulatory effects. Smaller players like CannaVEST Corp. (CANV) are finding the market wide open too and CannaVEST has managed to establish a considerable CBD supply business, while also working on a range of industrial hemp-derived CBD nutraceuticals. Industrial hemp is widely known for its low THC levels and comparatively higher levels of CBD, making it an ideal source for developing health and wellness products intended to treat a whole host of conditions, from chronic pain and epilepsy, to diabetes. Even various neurological disorders like ADHD and Parkinson's disease are among the immediate prospects for CBD-rich offerings, according to Project CBD.
CBD has even been shown to promote nutritional health in aging people, acting as an antioxidant and neuroprotectant, superbly suited to age-related inflammatory and autoimmune diseases. Pair the 10,000-plus Baby Boomers retiring per day (Pew Research) and Research and Markets' latest report on the U.S. nutraceutical market indicating a projected 6% CAGR through 2017, as the space swells to some $75.3B or more, and you get a perfect storm for CBD nutraceuticals.
Ready-Supply Inventory Model, Maximum Distribution Potential
One of the more compelling plays in the space today is Earth Science Tech, Inc. (ETST), which recently received its first two shipments of non-psychoactive, food-grade, CBD-enriched hemp oil, which is completely legal in 50 states and over 40 countries worldwide (as per U.S. Hemp Foods specifications). With over 50 liters from their first two shipments, an initial order already out the door to an outlet in Fort Lauderdale and management working hard to drum up additional supply lines, Earth Science Tech is rapidly moving towards widespread commercialization while setting themselves up to be a high-volume throughput channel for high-grade CBD. Perhaps more importantly, management is steadfastly committed to genuinely helping consumers get the best nutrition and dosing information possible, as well as creating shareholder upside. This was clearly demonstrated by the CEO in a recent video interview with leading cannabis investment news source, CannabisFN, when he said a salary won't be pursued until he knows the company is doing well.
CannabisFN Executive Interview | Earth Science Tech (ETST) from TDM Financial on Vimeo.
Earth Science Tech has already begun making their CBD products available online in half-ounce, ounce and two ounce bottles, and has made sizeable investments into their high-volume inventory model, with hundreds of thousands of dollars already outlaid and ambitions to fill persistent supply constraints in the CBD market via a steady stream of readily available product. Earth Science Tech has even funded assistant dean of the University of Central Oklahoma's College of Mathematics and Science, Wei R. Chen, Ph.D., with a $10k grant to study the anti-tumor effects of the such hemp oil enriched with CBD on cancer cells, pushing the boundaries of the established anti-tumor properties of CBD. Dr. Chen brings an impressive track record of over two decades in cancer research to the project as its lead and has noted that the project may result in a new understanding of the potential applications of this non-toxic and largely beneficial natural product.
Developing Nutraceutical Portfolio, Retail Footprint
Beyond raw CBD enriched hemp oil, Earth Science Tech is seeking to develop a variety of nutraceuticals, bioceuticals and dietary supplements for health, wellness, sports and alternative medicine, as well as natural alternatives to prescription medications, both CBD and non-CBD based. This is the same model employed to great success by companies like LifeVantage Corp. (LFVN), which notably cropped out into sports nutrition recently, extending their reach from a strong base in nutraceutical dietary supplements.
Earth Science Tech has developed a unique menopause and perimenopause formula for aging women known as ProgesteBeauty(TM), and the company is currently in the process of opening the first retail location for their wholly-owned Nutrition Empire, Inc. subsidiary in an upscale area of Coral Gables, Florida. The retail footprint will help support product roll outs and the company will also be working to dovetail their overall commercial presence with key strategic partners and third party resellers who already control chunks of the nutritional and supplement markets. Earth Science Tech has secured a lease for their initial retail location, which is situated right on the edge of the University of Miami campus, on the first floor of a luxury apartment complex, that stipulates no other nutrition or supplement store will be located within a three-mile radius. The location is right by a 24k square foot gourmet grocery store as well, in a premier shopping district with loads of foot traffic. This will also be the first retail store in all of Dade County where consumers can walk right in and buy CBD oil over the counter, as well as get their hands on ProgesteBeauty, or the company's soon-to-be-released, oxygen-based colon cleanser with probiotics (L. rhamnosus and L. acidophilus), OxyBiotic(TM). The goal is to have around 600 best-in-class health and wellness products in-store, as well as a terminal for customers to order products for next-day delivery, again emphasizing ready supply as a key brand hallmark.
Spartan Management Leveraging Top Consultants
Unlike many other companies in a similar position, which might tend to bloat the management team with a lot of extraneous personnel in order to try and cover all their bases, ETST has opted to create a lean and mean management team, tapping the best of the best in requisite fields to act as consultants. By maintaining a network of top-quality consultants, the kind of expert formulators responsible for the company's ProgesteBeauty and OxyBiotic formulas, ETST aims to keep management expenses down and yet remain highly competitive in the space.
For More Information Visit Earth Sciences Company Website: http://www.earthsciencetech.com/.
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.
SOURCE: Emerging Growth LLC
ETST is proud to offer the finest, most natural and consistent High Grade CBD Rich Hemp Oil with no fillers, preservatives or additives. The company's CBD Rich Hemp Oil is made for consumers who want the highest quality natural CBD. ETST High Grade CBD (Cannabidiol) Rich Hemp Oil is natural and formulated using a wide array of cutting-edge technologies such as super critical extraction, isolation, and micron filtration. It is lab tested multiple times during the manufacturing process, from seed to shelf. This also includes being tested for CBD content, other Cannabinoid content, yeast/mold/fungus, and bacteria like E. coli to ensure safety and top quality. Cannabidiol (CBD) is a naturally occurring constituent of the hemp plant (seed, stem and stalk). It is the most abundant non-psychoactive cannabinoid in hemp (cannabis), and is commonly used as a dietary supplement to support general health, immune system support, nervous system and much more. Research shows that many scientists and doctors think the cannabinoids work synergistically to support the whole human endo-cannabinoid system (internal and natural human cannabinoid system). Furthermore, many scientists and doctors believe the endo-cannabinoid system plays a fundamental role in the functioning of many of the major human physiological systems, including the immune and nervous systems.
ETST is capable of supplying and offering its High Grade CBD Rich Hemp Oil in all 50 states and over 40 countries as a nutritional and dietary supplement designed to support overall health and wellness.
ETST invites all interested parties to contact the company directly at firstname.lastname@example.org in regards to securing its All Natural High Grade CBD (Cannabidiol) Rich Hemp Oil for wholesale, resale, private labeling or distribution. ETST is open to forming new strategic partnerships, joint ventures and/or supplying vendors, resellers and third party distribution companies with its High Grade CBD Rich Hemp Oil at wholesale prices in order to better help supply the health and wellness markets on a large scale. The company feels it can grow at a much faster pace by focusing on becoming a large wholesale distributor of its High Grade CBD Rich Hemp Oil and by aligning itself with key strategic partners and third party resellers that are already well diversified in the Health and Wellness markets. ETST's High Grade CBD Rich Hemp Oil is All Natural and derived completely from the federally legal industrial hemp plant. Industrial Hemp (Hemp) is not marijuana and will not get you 'high' and it does not require a medical license of any kind to authorize purchase. Hemp oil contains CBD -- a non-psychoactive compound of the plant. There are millions of hemp oil consumers around the world and this number is rapidly rising with an increasing number of reports and studies showing a variety of benefits of hemp oil. ETST is now offering the availability for the Health and Wellness markets, consumers and its shareholders to try its All Natural High Grade CBD Rich Hemp Oil in small quantities at wholesale prices online at http://www.earthsciencetech.com/cbd-rich-hemp-oil/.
ABOUT ETST: ETST is a unique Biotechnology company focused on delivering cutting edge Nutraceuticals, Bioceuticals and Dietary Supplements designed for excellence in the areas of Health, Wellness, Sports and Alternative Medicine and to improving the quality of life for Consumers Worldwide. ETST is also dedicated to providing Natural Alternatives to prescription medications through Nutritional Supplements and Dietary Supplements that help improve common disorders and illnesses. This may include products such as CBD (Cannabidiol) as a natural constituent of Hemp Oil, Vitamins, Minerals, Herbs, Botanicals, Personal Care Products, Homeopathies, Functional Foods and other products. These products may be in various formulations and delivery systems including (but not limited to) capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs.
ETST is focused on researching and developing innovative Hemp extracts and to make them accessible Worldwide. ETST plans to be the premier supplier of the highest quality Hemp Oil Enriched with High Grade CBD (Cannabidiol). ETST primary goal is to advance different High Quality Hemp extracts with a broad profile of Cannabinoids and additional natural molecules found in Industrial Hemp and to identify their distinct properties. The company is dedicated in offering its consumers the finest and purest quality All Natural CBD Rich Hemp oil while never compromising on quality. This High Grade CBD (Cannabidiol) Rich Hemp oil is classified as "food based" and therefore perfectly permissible in all 50 states and more than 40 countries. Cannabinoids (Cannabidiol/CBD) are natural constituents of the Hemp plant and CBD is derived from Hemp stalk and seed. Hemp oil is a well-known dietary supplement and the naturally occurring CBD possesses no psychoactive qualities and presents a continuing stream of overwhelming evidence of significant Health and Wellness benefits. With no psychoactive ingredient, CBD is a ready-for-market Hemp-based Nutraceutical. According to scientific and clinical studies, CBD has the potential to help a range of conditions including epilepsy, diabetes, rheumatoid arthritis, chronic pain, alcoholism, schizophrenia, PTSD, antibiotic-resistant infections, and various neurological disorders (Source: National Center for Biotechnology Information http://www.ncbi.nlm.nih.gov). CBD has moreover exhibited Neurogenic and Neuroprotective effects and its anti-cancer properties are currently being investigated at several academic research centers in the United States and abroad. The United States Food and Drug Administration (FDA) currently considers non-THC hemp based cannabinoids, including CBD, to be "food based" and therefore saleable. These new non-psychoactive CBD-rich hemp oil products that ETST has geared up to market and distribute are beyond reproach and available to consumers in all 50 states and in more than 40 countries. CBD (cannabidiol), a naturally occurring constituent of the industrial hemp plant, promotes and supports the nutritional health of aging bodies in particular. Source: US Government Patent #6,630,507 "Cannabinoids as antioxidants and neuroprotectants."
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
FORWARD LOOKING DISCLAIMER: This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at http://www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk facts that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.
Embedded Video Available: http://vimeo.com/106424035
Earth Science Tech, Inc.
Phone: +1(561) 705-1278
SOURCE: Earth Science Tech, Inc.
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated one thousand six hundred dollars for Earth Science Tech, Inc. news coverage by the Company. FNMG HOLDS NO SHARES OF Earth Science Tech, Inc.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.